Regional gray matter abnormalities in panic disorder: a voxel-based morphometry study.

The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology (2010) 4.82

From threat to fear: the neural organization of defensive fear systems in humans. J Neurosci (2009) 1.94

The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. PLoS One (2015) 1.39

Gray matter abnormalities in social anxiety disorder: primary, replication, and specificity studies. Biol Psychiatry (2012) 0.99

Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder. PLoS One (2009) 0.97

Panic disorder: is the PAG involved? Neural Plast (2009) 0.95

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. World J Biol Psychiatry (2016) 0.92

The clinical implications of mouse models of enhanced anxiety. Future Neurol (2011) 0.89

Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm (Vienna) (2012) 0.86

The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies. PLoS One (2014) 0.86

EEG microstate analysis in drug-naive patients with panic disorder. PLoS One (2011) 0.84

The ecology of human fear: survival optimization and the nervous system. Front Neurosci (2015) 0.84

Vulnerability to simple faints is predicted by regional differences in brain anatomy. Neuroimage (2009) 0.83

Abnormal activity-dependent brain lactate and glutamate+glutamine responses in panic disorder. Biol Psychiatry (2013) 0.83

Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders. Br J Psychiatry (2015) 0.83

Acid-base dysregulation and chemosensory mechanisms in panic disorder: a translational update. Transl Psychiatry (2015) 0.80

The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies. Biol Mood Anxiety Disord (2012) 0.80

Injured brain regions associated with anxiety in Vietnam veterans. Neuropsychologia (2013) 0.79

Interoception and stress. Front Psychol (2015) 0.79

New perspective on the pathophysiology of panic: merging serotonin and opioids in the periaqueductal gray. Braz J Med Biol Res (2012) 0.77

A review of neuroimaging studies of anxiety disorders in China. Neuropsychiatr Dis Treat (2011) 0.77

The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry. Transl Psychiatry (2016) 0.77

Early life stress and the anxious brain: evidence for a neural mechanism linking childhood emotional maltreatment to anxiety in adulthood. Psychol Med (2015) 0.76

The neuroanatomical correlates of anxiety in a healthy population: differences between the State-Trait Anxiety Inventory and the Hamilton Anxiety Rating Scale. Brain Behav (2014) 0.76

Voxel-based morphometry predicts shifts in dendritic spine density and morphology with auditory fear conditioning. Nat Commun (2015) 0.76

Orbito-frontal cortex volumes in panic disorder. Psychiatry Investig (2012) 0.76

Sensory migraine aura is not associated with structural grey matter abnormalities. Neuroimage Clin (2016) 0.75

Multiple white matter volume reductions in patients with panic disorder: relationships between orbitofrontal Gyrus volume and symptom severity and social dysfunction. PLoS One (2014) 0.75

The Explorative Analysis to Revise Fear Network Model for Panic Disorder: Functional Connectome Statistics. Medicine (Baltimore) (2016) 0.75

Gray matter volumes in symptomatic and asymptomatic offspring of parents diagnosed with bipolar disorder. Eur Child Adolesc Psychiatry (2016) 0.75

Reduced Cortical Thickness in the Temporal Pole, Insula, and Pars Triangularis in Patients with Panic Disorder. Yonsei Med J (2017) 0.75

(Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta (2008) 1.59

Resting-state functional connectivity in normal brain aging. Neurosci Biobehav Rev (2013) 1.55

Cavum septum pellucidum and adhesio interthalamica in schizophrenia: an MRI study. Eur Psychiatry (2006) 1.54

Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiol Aging (2009) 1.46

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol (2010) 1.31

Regional gray matter abnormalities in obsessive-compulsive disorder: a voxel-based morphometry study. Biol Psychiatry (2005) 1.30

Is the full version of the AUDIT really necessary? Study of the validity and internal construct of its abbreviated versions. Alcohol Clin Exp Res (2010) 1.24

Localized cerebral blood flow reductions in patients with heart failure: a study using 99mTc-HMPAO SPECT. J Neuroimaging (2005) 1.20

Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis--potentially implicated mechanisms. Br J Pharmacol (2002) 1.14

Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Res (2006) 1.13

Acquired hepatocerebral degeneration and hepatic encephalopathy: correlations and variety of clinical presentations in overt and subclinical liver disease. Arq Neuropsiquiatr (2011) 1.11

A proposed sequence of events for cadmium-induced mitochondrial impairment. J Inorg Biochem (2003) 1.11

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10

Age-related gray matter volume changes in the brain during non-elderly adulthood. Neurobiol Aging (2009) 1.10

State-dependent microstructural white matter changes in bipolar I depression. Eur Arch Psychiatry Clin Neurosci (2009) 1.10

Reduced cortical folding in schizophrenia: an MRI morphometric study. Am J Psychiatry (2003) 1.08

Anxiolytic-like effect of oxytocin in the simulated public speaking test. J Psychopharmacol (2011) 1.07

5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol (2009) 1.05

Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study. Neuroreport (2007) 1.05

Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry (2014) 1.05

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.03

Animal models of anxiety disorders and stress. Rev Bras Psiquiatr (2013) 1.03

Adhesio interthalamica alterations in schizophrenia spectrum disorders: A systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.03

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology (Berl) (2010) 1.02

Relationship between regional cerebral blood flow and separate symptom clusters of major depression: a single photon emission computed tomography study using statistical parametric mapping. Neurosci Lett (2005) 1.01

Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br J Pharmacol (2011) 1.00

Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis (2010) 0.99

Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis. Schizophr Res (2009) 0.98

Seeing with the eyes shut: neural basis of enhanced imagery following Ayahuasca ingestion. Hum Brain Mapp (2011) 0.97

Surgical treatment for mesial temporal lobe epilepsy in the presence of massive calcified neurocysticercosis. Arch Neurol (2004) 0.97

Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol (2008) 0.97

White matter abnormalities associated with Alzheimer's disease and mild cognitive impairment: a critical review of MRI studies. Expert Rev Neurother (2013) 0.96

Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications. Clinics (Sao Paulo) (2011) 0.96

Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol (2010) 0.95

Insight and regional brain volumes in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.95

Neurobiology of panic disorder: from animal models to brain neuroimaging. Neurosci Biobehav Rev (2008) 0.95

Grey matter abnormalities in Brazilians with first-episode psychosis. Br J Psychiatry Suppl (2007) 0.95

Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. Eur J Pharmacol (2007) 0.94

Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophr Res (2010) 0.94

Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl) (2009) 0.94

Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. Eur J Pharmacol (2008) 0.93

On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment. Neuropsychopharmacology (2012) 0.93

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. Eur J Pharmacol (2005) 0.93

The interaction of flavonoids with mitochondria: effects on energetic processes. Chem Biol Interact (2005) 0.92

Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking. Eur Neuropsychopharmacol (2005) 0.92

Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. J Affect Disord (2002) 0.92

Structural magnetic resonance imaging in anxiety disorders: an update of research findings. Rev Bras Psiquiatr (2008) 0.92

Heterogeneity of coordinate-based meta-analyses of neuroimaging data: an example from studies in OCD. Br J Psychiatry (2010) 0.90

Elevated mazes as animal models of anxiety: effects of serotonergic agents. An Acad Bras Cienc (2007) 0.89

Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats. Behav Brain Res (2006) 0.89

Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur Neuropsychopharmacol (2008) 0.89

Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.88

Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol (2010) 0.88

Evaluation of functional stability of quercetin as a raw material and in different topical formulations by its antilipoperoxidative activity. AAPS PharmSciTech (2006) 0.88

The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes. J Pharmacol Exp Ther (2002) 0.88

Neuroanatomical pattern classification in a population-based sample of first-episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.87

In situ evidence of an alternative oxidase and an uncoupling protein in the respiratory chain of Aspergillus fumigatus. Int J Biochem Cell Biol (2004) 0.87

Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors. Behav Pharmacol (2010) 0.87

Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord (2008) 0.87

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system. Int J Neuropsychopharmacol (2013) 0.87

Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.87

Treatment of resistant obsessive-compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study. J Neuropsychiatry Clin Neurosci (2009) 0.87

Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats. Neuropsychopharmacology (2011) 0.87

The stability of the blood oxygenation level-dependent functional MRI response to motor tasks is altered in patients with chronic ischemic stroke. Stroke (2010) 0.86

Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry (2013) 0.86

Subtle gray matter changes in temporo-parietal cortex associated with cardiovascular risk factors. J Alzheimers Dis (2011) 0.86

Antidepressant-like effects of N-acetyl-L-cysteine in rats. Behav Pharmacol (2008) 0.85

Brain activity patterns during phonological verbal fluency performance with varying levels of difficulty: a functional magnetic resonance imaging study in Portuguese-speaking healthy individuals. J Clin Exp Neuropsychol (2011) 0.85

Seizure outcome after surgery for epilepsy due to focal cortical dysplastic lesions. Seizure (2006) 0.85

Effects of diazepam on BOLD activation during the processing of aversive faces. J Psychopharmacol (2010) 0.85

Validity of the PHQ-2 for the screening of major depression in Parkinson's disease: two questions and one important answer. Aging Ment Health (2011) 0.85

Anti-aversive effects of the atypical antipsychotic, aripiprazole, in animal models of anxiety. J Psychopharmacol (2010) 0.85

Lateral ventricle differences between first-episode schizophrenia and first-episode psychotic bipolar disorder: A population-based morphometric MRI study. World J Biol Psychiatry (2010) 0.85

White-matter hyperintensities in first-episode psychosis. Br J Psychiatry (2008) 0.84

Antioxidant activity of isocoumarins isolated from Paepalanthus bromelioides on mitochondria. Phytochemistry (2007) 0.84

Obsessive-compulsive symptom dimensions correlate to specific gray matter volumes in treatment-naïve patients. J Psychiatr Res (2012) 0.84

Cognitive deficits in first-episode psychosis: a population-based study in São Paulo, Brazil. Schizophr Res (2006) 0.84

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.84

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum. Life Sci (2004) 0.84

Immunohistochemical, tomographic and histological study on onlay iliac grafts remodeling. Clin Oral Implants Res (2008) 0.84

Inhibition of nitric oxide synthase increases synaptophysin mRNA expression in the hippocampal formation of rats. Neurosci Lett (2007) 0.83

Vascular diseases and old age mental disorders: an update of neuroimaging findings. Curr Opin Psychiatry (2010) 0.83

Family context and duration of untreated psychosis (DUP): results from the Sao Paulo Study. Schizophr Res (2009) 0.83

Phonemic fluency in Portuguese-speaking subjects in Brazil: ranking of letters. J Clin Exp Neuropsychol (2006) 0.83

Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats. Eur J Neurosci (2013) 0.83

Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking. Psychiatry Res (2005) 0.83